119 related articles for article (PubMed ID: 2911994)
1. Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide).
Hollenberg NK; Mickiewicz CW
Am J Cardiol; 1989 Jan; 63(4):37B-41B. PubMed ID: 2911994
[TBL] [Abstract][Full Text] [Related]
2. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
Hollenberg NK; Bannon JA
Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
[No Abstract] [Full Text] [Related]
3. Hyperkalemia in diabetes mellitus. Effect of a triamterene-hydrochlorothiazide combination.
Hollenberg NK; Mickiewicz C
Arch Intern Med; 1989 Jun; 149(6):1327-30. PubMed ID: 2730251
[TBL] [Abstract][Full Text] [Related]
4. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide).
Blume CD; Williams RL
Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of triamterene/hydrochlorothiazide combinations in mild systemic hypertension.
Schnaper HW; Maxwell MH
Am J Cardiol; 1989 Jan; 63(4):32B-36B. PubMed ID: 2643290
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
Casner PR; Dillon KR
J Clin Pharmacol; 1990 Aug; 30(8):715-9. PubMed ID: 2401750
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and tolerability of a fixed-dose combination of antihypertensive agents: an open-label surveillance study in China.
Wu Y; Hu Y; Tang X; He L; Ren T; Tao Q; Qin X; Sun N; Wang H; Cao W; Wu T; Zhan S; Wang J; Chen W; Li L
Clin Drug Investig; 2011 Nov; 31(11):769-77. PubMed ID: 21671689
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
Williams RL; Clark T; Blume CD
Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
Zawada ET
Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
[TBL] [Abstract][Full Text] [Related]
10. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of hypertension with a fixed calcium antagonist-diuretic combination. Observations from treatment of 5,595 patients].
Klaus D
Fortschr Med; 1995 Mar; 113(7):90-6. PubMed ID: 7750891
[TBL] [Abstract][Full Text] [Related]
12. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
[No Abstract] [Full Text] [Related]
13. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.
Cocke TB; Fisch S; Gilmore HR; Okun R; Tamagna IG; Wipplinger K
J Clin Pharmacol; 1977; 17(5-6):334-8. PubMed ID: 323298
[TBL] [Abstract][Full Text] [Related]
14. Treating essential hypertension. The first choice is usually a thiazide diuretic.
Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
[TBL] [Abstract][Full Text] [Related]
15. Managing hypertension in family practice: a nationwide collaborative study of the use of four antihypertensives in the treatment of mild-to-moderate hypertension. A report from CEN. Clinical Experience Network.
J Am Board Fam Pract; 1989; 2(3):172-90; discussion 190. PubMed ID: 2546375
[TBL] [Abstract][Full Text] [Related]
16. Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension.
Papademetriou V; Price M; Johnson E; Smith M; Freis ED
Am J Cardiol; 1984 Nov; 54(8):1015-9. PubMed ID: 6496322
[TBL] [Abstract][Full Text] [Related]
17. Captopril versus hydrochlorothiazide/triamterene in mild-to-moderate hypertension in the elderly.
Woo J; Woo KS; Vallance-Owen J
Lancet; 1986 Oct; 2(8512):924. PubMed ID: 2876357
[No Abstract] [Full Text] [Related]
18. Serum magnesium and potassium levels in hypertensive patients after a therapeutic switch from hydrochlorothiazide plus a potassium supplement to maxzide.
Davidov ME; Becker FE; Hollifield JW
Am J Med; 1987 Mar; 82(3A):48-51. PubMed ID: 3565425
[TBL] [Abstract][Full Text] [Related]
19. Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly.
Fletcher A; Amery A; Birkenhäger W; Bulpitt C; Clement D; de Leeuw P; Deruyterre ML; de Schaepdryver A; Dollery C; Fagard R
J Hypertens; 1991 Mar; 9(3):225-30. PubMed ID: 1851785
[TBL] [Abstract][Full Text] [Related]
20. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
McClennen W; Wilson T
Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
